Except microsatellite instability, tumor markers which reflect the heterogeneity of CRC include: the CpG island methylator phenotype (CIMP), as well as somatic point mutations in BRAF and KRAS, and other molecular genetic markers, TP53 and PIK3CA for example[40–42]. This evidence concerns the gene TP53 and neoplasm.